Clinical Hematology International, 2020 Dose-adjusted rituximab, etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin (DA.R-EPOCH) is used for upfront treatment of high-risk diffuse large B cell lymphoma (DLBCL).
Bhagirathbhai Dholaria +7 more
doaj +1 more source
Multifocal primary cutaneous extranodal NK/T lymphoma nasal type [PDF]
Anais Brasileiros de Dermatologia, 2016 Nasal type extranodal NK/T-cell lymphoma is a distinct entity according to the World Health Organization classification. Although 60% to 90% of patients with this disease present with a destructive mass in the midline facial tissues, it may also ...
Pedro de Vasconcelos +3 more
doaj +1 more source
Management of Febrile Neutropenia - a German Prospective Hospital Cost Analysis in Lymphoproliferative Disorders, Non-Small Cell Lung Cancer, and Primary Breast Cancer [PDF]
, 2011 Background: Febrile neutropenia/leukopenia (FN/FL) is the most frequent dose-limiting toxicity of myelosuppressive chemotherapy, but German data on economic consequences are limited.
Angela Ihbe-Heffinger +19 more
core +1 more source
Dental treatment considerations in the chemotherapy patient [PDF]
, 2011 Cancer patients can suffer oral toxic effects secondary to antineoplastic therapy in the form of radiotherapy and/ or chemotherapy. This risk is conditioned by a range of factors, including the high cell turnover rate of the oral mucosa, the diversity ...
Chaveli López, Begonya +2 more
core +1 more source
Adverse drug reaction: a comparative analysis of protocols used for treatment of colorectal cancer
Medicina, 2017 Study design: Cohort study Objective: Analyze the adverse reactions that occurred in Brazilian patients with colorectal cancer submitted to chemotherapy with two different protocols, in order to identify the types and severity of those most frequent ...
Marcela Maciel Melo +2 more
doaj +1 more source
Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials. [PDF]
, 2013 PurposePatients with advanced cholangiocarcinoma (CC) and gallbladder carcinoma (GC) have few therapeutic options for relapsed disease. methods: Given the overall poor prognosis in this population and the availability of novel targeted therapies, we ...
Falchook, Gerald S +14 more
core +2 more sources
Educational interventions for the management of cancer-related fatigue in adults [PDF]
, 2016 Background: Cancer-related fatigue is reported as the most common and distressing symptom experienced by patients with cancer. It can exacerbate the experience of other symptoms, negatively affect mood, interfere with the ability to carry out everyday ...
Beller, Elaine M +5 more
core +2 more sources
Associated factors of hope in cancer patients during treatment : a systematic literature review [PDF]
, 2020 Aim: To identify the associated factors of hope during treatment in cancer patients. Background: Hope is very important to cancer patients at all stages of the disease process. Hope is seen as an important coping mechanism.
Grypdonck, Maria +3 more
core +1 more source
Gestational trophoblastic disease [PDF]
Archive of Oncology, 2002 Gestational trophoblastic disease belongs to a spectrum of rare tumors originating from trophoblast. It spreads from the benignant disease uncomplicated partial mole to the most malignant choriocarcinoma in stage IV of disease with brain metastases ...
Živaljević Milica +4 more
doaj +1 more source
Xeloda as first-line therapy of metastatic colorectal cancer-our experience [PDF]
Archive of Oncology, 2002 BACKGROUND: Results of phase III clinical studies comparing efficacy of Xeloda vs. standard 5-FU/FA protocols as first line therapy of metastatic colorectal carcinoma (MCRC), have shown better efficacy of Xeloda, with less toxic adverse effects, apart ...
Kovčin Vladimir +4 more
doaj +1 more source